Head-to-head · WeighScore
Idgie Health vs YOURx Health
By GLP-1 ScorecardUpdated
Score comparison
Idgie Health has the higher recorded score — 75.4/100 to 70/100.
Idgie Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Publishes the amount billed today at every rung and names its 503A class — then describes a recurring Membership Fee only in the Terms.
Before you choose
Before comparing the headline prices, the Idgie Health review and the YOURx Health review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.
If neither one fits, Idgie Health vs Zera Health and June Health vs YOURx Health compare each of them with another graded program, and the list of alternatives to Idgie Health ranks the programs closest to Idgie Health on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the Collective review covers one graded close to these two, at 71.6/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Idgie Health | YOURx Health |
|---|---|---|
| WeighScore | 75.4/100 | 70/100 |
| Grade | C | C |
| Site position | #57 | #123 |
| Semaglutide | $149/mo month-to-month ($114 only on a 6-month prepay) | $159/mo (advertised injection price) |
| Tirzepatide | $229/mo month-to-month ($171 only on a 6-month prepay) | $179/mo (advertised injection price) |
| Coverage | A state-availability page is published | Coverage not published |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Yes | Yes |
Strengths
- Every rung carries the figure billed today — $387 at three months, $687 at six on semaglutide — not just a per-month number
- States the pharmacy class plainly: prescriptions ship from a licensed U.S. 503A pharmacy
- Names its operating entity, Feel Better Health Group, LLC, in the page footer rather than only in the Terms
- The plan covers the provider evaluation, all injection supplies, dose titration, unlimited provider messaging and free shipping
- An oral semaglutide and two microdose lines sit beside the injection
What to consider
- Both headlines are the six-month prepay: "From $114" against $149, and "From $171" against $229
- The Terms describe a recurring Membership Fee and exclude the online visit and labs from it, while the pricing page never uses the word and promises no hidden fees
- The same Terms name an Idgie Health Pharmacy Network and a Bask Pharmacy Network without dividing the work between them
- The semaglutide card says "all doses"; the tirzepatide card does not
Strengths
- Separately lists prices for injections and dissolving tablets
- Identifies YOURx Health LLC as the operator
What to consider
- Checkout determines the selected plan and renewal terms
- Prescription cancellation closes once pharmacy fulfillment begins
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.